These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

127 related items for PubMed ID: 3491879

  • 1. Characterization of the binding of N-methyl-4-phenylpyridine, the toxic metabolite of the parkinsonian neurotoxin N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine, to neuromelanin.
    D'Amato RJ, Benham DF, Snyder SH.
    J Neurochem; 1987 Feb; 48(2):653-8. PubMed ID: 3491879
    [Abstract] [Full Text] [Related]

  • 2. Selectivity of the parkinsonian neurotoxin MPTP: toxic metabolite MPP+ binds to neuromelanin.
    D'Amato RJ, Lipman ZP, Snyder SH.
    Science; 1986 Feb 28; 231(4741):987-9. PubMed ID: 3080808
    [Abstract] [Full Text] [Related]

  • 3. Neuromelanin: a role in MPTP-induced neurotoxicity.
    D'Amato RJ, Alexander GM, Schwartzman RJ, Kitt CA, Price DL, Snyder SH.
    Life Sci; 1987 Feb 23; 40(8):705-12. PubMed ID: 2880274
    [Abstract] [Full Text] [Related]

  • 4. 1-Methyl-4-phenylpyridinium ion (MPP+): identification of a metabolite of MPTP, a toxin selective to the substantia nigra.
    Langston JW, Irwin I, Langston EB, Forno LS.
    Neurosci Lett; 1984 Jul 13; 48(1):87-92. PubMed ID: 6332288
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Selective accumulation of MPP+ in the substantia nigra: a key to neurotoxicity?
    Irwin I, Langston JW.
    Life Sci; 1985 Jan 21; 36(3):207-12. PubMed ID: 3871240
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Oxygen activation during the interaction between MPTP metabolites and synthetic neuromelanin--an ESR-spin trapping, optical, and oxidase electrode study.
    Korytowski W, Felix CC, Kalyanaraman B.
    Biochem Biophys Res Commun; 1988 Jul 29; 154(2):781-8. PubMed ID: 2840906
    [Abstract] [Full Text] [Related]

  • 11. Melanized dopaminergic neurons are differentially susceptible to degeneration in Parkinson's disease.
    Hirsch E, Graybiel AM, Agid YA.
    Nature; 1988 Jul 28; 334(6180):345-8. PubMed ID: 2899295
    [Abstract] [Full Text] [Related]

  • 12. The toxic actions of MPTP and its metabolite MPP+ are not mimicked by analogues of MPTP lacking an N-methyl moiety.
    Bradbury AJ, Costall B, Domeney AM, Testa B, Jenner PG, Marsden CD, Naylor RJ.
    Neurosci Lett; 1985 Oct 24; 61(1-2):121-6. PubMed ID: 2417166
    [Abstract] [Full Text] [Related]

  • 13. Astrocytes convert the parkinsonism inducing neurotoxin, MPTP, to its active metabolite, MPP+.
    Ransom BR, Kunis DM, Irwin I, Langston JW.
    Neurosci Lett; 1987 Apr 10; 75(3):323-8. PubMed ID: 3495754
    [Abstract] [Full Text] [Related]

  • 14. Active uptake of MPP+, a metabolite of MPTP, by brain synaptosomes.
    Chiba K, Trevor AJ, Castagnoli N.
    Biochem Biophys Res Commun; 1985 May 16; 128(3):1228-32. PubMed ID: 3873939
    [Abstract] [Full Text] [Related]

  • 15. Effects of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) on ultrastructure of nigral neuromelanin in Macaca fascicularis.
    Levi AC, DeMattei M, Ravazzani R, Corvetti G, Golden GT, Fariello RG.
    Neurosci Lett; 1989 Jan 30; 96(3):271-6. PubMed ID: 2785665
    [Abstract] [Full Text] [Related]

  • 16. Neuromelanin synthesis in rat and human substantia nigra.
    Rabey JM, Hefti F.
    J Neural Transm Park Dis Dement Sect; 1990 Jan 30; 2(1):1-14. PubMed ID: 2357268
    [Abstract] [Full Text] [Related]

  • 17. Pargyline prevents MPTP-induced parkinsonism in primates.
    Langston JW, Irwin I, Langston EB, Forno LS.
    Science; 1984 Sep 28; 225(4669):1480-2. PubMed ID: 6332378
    [Abstract] [Full Text] [Related]

  • 18. The importance of the '4-5' double bond for neurotoxicity in primates of the pyridine derivative MPTP.
    Langston JW, Irwin I, Langston EB, Forno LS.
    Neurosci Lett; 1984 Sep 07; 50(1-3):289-94. PubMed ID: 6333656
    [Abstract] [Full Text] [Related]

  • 19. Quantification of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine and 1-methyl-4-phenylpyridinium ion in brain tissue by gas chromatography/mass spectrometry.
    Shih MC, Markey SP.
    Biomed Environ Mass Spectrom; 1986 Feb 07; 13(2):85-9. PubMed ID: 2937483
    [Abstract] [Full Text] [Related]

  • 20. 1-methyl-4-phenylpyridine is neurotoxic to the nigrostriatal dopamine pathway.
    Bradbury AJ, Costall B, Domeney AM, Jenner P, Kelly ME, Marsden CD, Naylor RJ.
    Nature; 1986 Feb 07; 319(6048):56-7. PubMed ID: 3484542
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.